Atorvastatin Inhibits Ferroptosis of H9C2 Cells by regulatingSMAD7/Hepcidin Expression to Improve Ischemia-Reperfusion Injury
Cardiology Research and Practice · 08.11.2022 · 2022 · 1-12
DOI: 10.1155/2022/3972829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Research and Practice, erschienen am 08.11.2022. Verfasst von You Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Cardiology & Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention & Guangxi…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Health Committee Foundation, Key Scientific Research Project of Hunan Provincial Department of Education, Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases.
Abstract (Originalsprache)
Background
Ferroptosis plays a key role in cardiomyopathy. Atorvastatin (ATV) has a protective effect on ischemia-reperfusion (I/R) cardiomyopathy. The purpose of this study is to elucidate the mechanism of ATV in I/R injury.
Methods
H9C2 cells and cardiomyopathy rats were induced by hypoxia/reoxygenation (H/R) and I/R to construct in vitro and in vivo models. Cell viability was determined by CCK8. Cardiac histopathology was observed by HE staining. Transmission electron microscope (TEM) was used to observe the mitochondrial morphology. The reactive oxygen species (ROS) content in cells was analyzed by the biochemical method. ELISA was conducted to calculate the concentrations of total iron/Fe2+ and hepcidin. The expression of ferroptosis and SMAD pathway-related genes were detected by qPCR. Western blot was performed to detect the expression levels of ferroptosis and SMAD pathway-related proteins.
Results
In H9C2 cells, ATV reversed the decline in cell viability, mitochondrial shrinkage, and ROS elevation induced by erastin or H/R. The concentration of total iron and Fe2+ in H/R-induced H9C2 cells increased, and the protein expression of FPN1 decreased. After ATV treatment, the concentration of total iron and Fe2+ decreased, and the protein expression of FPN1 increased. The expression of the SMAD7 gene in H/R-induced H9C2 cells decreased, and the expression of the hepcidin gene increased, which were reversed by ATV. When SMAD7 was knocked down, ATV treatment failed to produce the above effect. ATV also improved ferroptosis in I/R rat myocardium through the SMAD7/hepcidin pathway.
Conclusions
ATV reversed the decline in H9C2 cell viability, mitochondrial shrinkage, and ROS elevation, and improved the myocardium ferroptosis through the SMAD7/hepcidin pathway in I/R rat.
Autor:innen und Institutionen
- Department of Geriatric Cardiology & Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention & Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases, The Fir…
- Department of Geriatric, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China.
- Hunan Research Institute of Geriatrics, Changsha, Hunan, China.
ORCID-Profile: Zhi-Yu Zeng
Förderung
- Hunan Provincial Health Committee Foundation
- Key Scientific Research Project of Hunan Provincial Department of Education
- Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases
- Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention
Zitieren
APA
Peng, Y., Liao, B., Zhou, Y., Zeng, W., & Zeng, Z. Y. (2022). Atorvastatin Inhibits Ferroptosis of H9C2 Cells by regulatingSMAD7/Hepcidin Expression to Improve Ischemia-Reperfusion Injury. Cardiology Research and Practice, 2022, 1-12. https://doi.org/10.1155/2022/3972829
Vancouver
Peng Y, Liao B, Zhou Y, Zeng W, Zeng ZY. Atorvastatin Inhibits Ferroptosis of H9C2 Cells by regulatingSMAD7/Hepcidin Expression to Improve Ischemia-Reperfusion Injury. Cardiology Research and Practice. 2022;2022:1-12. doi:10.1155/2022/3972829
BibTeX
@article{Peng2022,
author = {Peng, You and Liao, Bin and Zhou, Yan and Zeng, Wei and Zeng, Zhi-Yu},
title = {Atorvastatin Inhibits Ferroptosis of H9C2 Cells by regulatingSMAD7/Hepcidin Expression to Improve Ischemia-Reperfusion Injury},
journal = {Cardiology Research and Practice},
year = {2022},
volume = {2022},
pages = {1--12},
doi = {10.1155/2022/3972829}
}
EUVIMED